Share on StockTwits

Shares of MiMedx Group (NASDAQ:MDXG) saw a significant increase in short interest in the month of January. As of March 31st, there was short interest totalling 8,896,687 shares, an increase of 29.7% from the March 14th total of 6,858,753 shares, Analyst RN reports. Currently, 10.8% of the shares of the stock are sold short. Based on an average daily volume of 1,163,461 shares, the short-interest ratio is presently 7.6 days.

MiMedx Group (NASDAQ:MDXG) opened at 5.65 on Tuesday. MiMedx Group has a 1-year low of $1.81 and a 1-year high of $8.80. The stock’s 50-day moving average is $6.60 and its 200-day moving average is $6.62. The company’s market cap is $596.5 million.

MiMedx Group (NASDAQ:MDXG) last posted its quarterly earnings results on Wednesday, February 26th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.03. The company had revenue of $18.00 million for the quarter, compared to the consensus estimate of $18.31 million. During the same quarter in the previous year, the company posted ($0.02) earnings per share. The company’s revenue for the quarter was up 71.4% on a year-over-year basis. Analysts expect that MiMedx Group will post $-0.01 EPS for the current fiscal year.

MiMedx Group, Inc is a development-stage company. The Company is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membrane.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.